EyeTechCare

EyeTechCare

EyeTechCare developed the EyeOP1, an ultrasound device offering non-invasive treatments for refractory glaucoma. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Jan 2016.)
Company register number 505187526
Rillieux-la-Pape Auvergne-Rhône-Alpes (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR20142015
Revenues<1m<1m
% growth-(3 %)
EBITDA-(3.0m)
% EBITDA margin-(479 %)
Profit(3.1m)(3.4m)
% profit margin(477 %)(538 %)

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

€10.0m

Series C

€25.0m

Series D
Total Funding€35.0m

Recent News about EyeTechCare

Edit
More about EyeTechCareinfo icon
Edit

Eye Tech Care specializes in the development and manufacturing of non-invasive medical devices for the treatment of glaucoma. Utilizing advanced focused ultrasound technology, their devices provide a quick, incision-free procedure that can be completed in just five minutes. This innovative approach allows for repeatable treatments, making it a long-term solution for glaucoma management. The company primarily serves ophthalmologists and healthcare providers who treat patients with glaucoma, a condition affecting millions worldwide. Operating in the medical device market, Eye Tech Care's business model revolves around the sale of their CE-marked class IIb medical devices to healthcare institutions. Revenue is generated through direct sales and partnerships with medical distributors. The company is headquartered in Rillieux-la-Pape, France, and is committed to addressing the global health burden of glaucoma, which is a leading cause of blindness.

Keywords: glaucoma, non-invasive, ultrasound, medical device, ophthalmology, CE-marked, healthcare, treatment, innovation, repeatable.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.